Latest News
From the Journals
One in eight COVID patients likely to develop long COVID: Large study
“This finding shows that post–COVID-19 condition is an urgent problem with a mounting human toll.”
From the Journals
Anti-BDCA2 antibody meets primary endpoint in phase 2 cutaneous lupus trial
In the phase 2 study, improvements in the Cutaneous Lupus Erythematosus Disease Area and Severity Index–Activity score were seen in patients...
Feature
Doctor faces apparent retaliation after alleging data manipulation in published trial
Rheumatologist Fouad Fayad alleged that the researchers tested patient samples multiple times and used a mix of old and new values in their...
Feature
Registry launched to reach more patients with PF
The major impetus behind the PFF Community Registry was to gather a more diverse representative sample of PF patients.
Feature
Why exercise doesn’t help people with long COVID
“We have participants in our study who had relatively mild acute symptoms and went on to have really profound decreases in their ability to...
From the Journals
COVID-19 and IPF: Fundamental similarities found
“This biomarker could indicate who is at greatest risk for progressive fibrosis.”
Latest News
Haven’t had COVID yet? Wanna bet?
These silent COVID-19 cases reflect a hidden side of the pandemic that may be helping to drive new surges and viral variants.
Latest News
Long COVID comes in three forms: Study
“These data show clearly that post-COVID syndrome is not just one condition but appears to have several subtypes.”
From the Journals
Gout flares linked to transient jump in MI, stroke risk
Causation is plausible, even suspected, say experts, who urge aggressive CV risk-factor management in gout patients and perhaps more willingness...
News from the FDA/CDC
Ustekinumab becomes second biologic approved for PsA in kids
The approval is based on an extrapolation of data from adult trials in active psoriatic arthritis and adult and pediatric studies in moderate to...
Latest News
COVID skin manifestations vary by type of variant, U.K. study finds
Omicron and Delta COVID-19 skin manifestations differ, according to large U.K. patient survey.